In this video, Motley Fool health-care analyst David Williamson discusses what investors can expect from Celgene's (NASDAQ:CELG) upcoming earnings report and what to look for going forward.

David Williamson has no position in any stocks mentioned, and neither does The Motley Fool. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.